Cannabis Investors Should Watch This Important Trend

This is a copy of the April 14th edition of our weekly Newsletter, which we have been publishing since October 2015.


Rapid growth and an increasing pace of consolidation in the market are drawing attention from investors and leading to appreciation in the prices of cannabis stocks, but this week we saw the beginning of what might develop into a near-term overhang on the market: Capital Raising.

While the equity and convertible debt offerings we tracked were not especially large in size, there were several announced this week, and some of them crushed the stocks involved. For example, Canadian LP Zenabis Global declined 28% on Friday after pricing a C$25 million Unit offering. Other companies raising capital in April included Canadian LPs Eve & Co (C$10 million) and Heritage Cannabis (C$15 million), Canadian Retailers High Tide (C$10 million) and Westleaf Cannabis (C$12 million), U.S. cannabis companies Cannsortium ($25 million) and Ionic Brands (C$20 million) and CBD companies Abacus Health Products (C$30 million) and Wildflower Brands (C$15 million). In aggregate, the amount being raised totaled about C$162 million, which is an amount that is not likely to have a major impact on the market unless it opens the floodgates to more deals. Greenlane is in the middle of an IPO that could add more than US$98 million.

When companies are raising capital, it can temporarily depress their own stock prices, but it can also weigh on the entire sector, as often investors will sell the stocks in other companies to fund new purchases. From our vantage, it seems as if money is continuing to flow into the sector, so fresh money should absorb most of the deals to date, minimizing the potential impact across the entire sector.

Over the past few years, clusters of capital-raising have resulted in sharp declines in the sector. Most recently, several MSOs raised capital in late Q3 and early Q4 ahead of going public and pressured stocks. Previously, there were two waves of capital raising by Canadian LPs that resulted in sharp pullbacks as well. While it’s too early to know how close we are to the point of too much near-term supply of stock pressuring the sector, we know that several companies could come to market given the recent filing of base shelf prospectuses by Aurora Cannabis, CannTrust, Charlotte’s Web, Emerald Health, HEXO Corp, MedMen, Neptune Wellness Solutions and Trulieve. So, for now, this is a trend to monitor and not yet a reason to fear a downturn.

Headset is a leading cannabis data and analytics provider, which turns retail data into real-time market insights. Identify opportunities in the emerging cannabis market by discovering the segments, brands, and products that are resonating with consumers, and/or understand market trends.

To learn more about Headset, which was built by the creators of Leafly and a client of New Cannabis Ventures, visit the company’s page that we maintain on its behalf and click the green Get More Info button.

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:

Join Alan Brochstein on April 17-18th for the Benzinga Cannabis Capital Conference. Use check-out code “NCV” to save 20% off.

To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.

Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.

View the Public Cannabis Company Revenue Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5m per quarter.

Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.

Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.

Consider subscribing to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013 for more in-depth information and market intelligence about the publicly traded cannabis sector.

Find your place in the cannabis industry by visiting our Careers and Jobs Page and learn which companies are hiring aggressively.


Alan & Joel

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter